Blueprint Medicines Corp Equity-NMS: BPMC

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$87.11
Open :$85.51
Today's high :$86
Today's low :$80.08
52W low :$80.08
52W high :$121.9
EPS(TTM): :-1.07
Shares O/S :63.91 M
Market cap :5.22 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Blueprint Medicines Corp $81.68 -2.32% - 5.22B

Frequently Asked Questions

What is the share price of Blueprint Medicines Corp today?

Blueprint Medicines Corp (BPMC) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Blueprint Medicines Corp

Blueprint Medicines Corporation is a fully integrated, commercial-stage, global biopharmaceutical company. The Company invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and PDGFRA Exon 18 mutant GIST in the United States and Europe. It has a pipeline of research and development programs that range from early science to advanced clinical trials in mast cell-mediated diseases, including systemic mastocytosis (SM) and chronic urticaria, breast cancer, and other solid tumors vulnerable to CDK2 inhibition. Its pipeline includes Elenestinib (BLU-263), BLU-808, and BLU-956. It is developing Elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders. It is advancing BLU-808, a potent and selective wild-type KIT inhibitor, for mast cell diseases.